After-Hours Movers 03/08: (GVP) (WX) (COO) (SBUX) Higher; (GMCR) (ZGNX) (HEK) Lower
Tweet
Share
E-mail
Get Alerts GVP Hot Sheet
Join SI Premium – FREE
GSE Systems, Inc. (NYSE: GVP) 25% HIGHER; reported Q4 EPS of $0.06, $0.05 better than the analyst estimate of $0.01. Revenue for the quarter came in at $15 million versus the consensus estimate of $13.2 million.
Green Mountain (Nasdaq: GMCR) 16.5% LOWER; shares slammed as Starbucks announced Verismo, a new Premium Single Cup Solution for At-Home Espresso and Coffee Beverages.
Zogenix, Inc. (NASDAQ: ZGNX) 14% LOWER; reported Q4 EPS of ($0.36), $0.02 worse than the analyst estimate of ($0.34). Revenue for the quarter came in at $7.9 million versus the consensus estimate of $10.03 million. Sees FY2012 revenue of $45.5-$48.5 million, versus the consensus of $64.9 million.
WuXi PharmaTech (NYSE: WX) 5.2% HIGHER; reported Q4 EPS of $0.36, $0.10 better than the analyst estimate of $0.26. Revenue for the quarter came in at $108.5 million versus the consensus estimate of $106.87 million. Sees FY2012 revenue of $468-$488 million, versus the consensus of $464.6 million. Sees Q1 2012 revenue of $114-$117 million, versus the consensus of $108 million.
Heckmann (NYSE: HEK) 5% LOWER; reported Q4 loss of $2.48 million, compared to a gain of $279,000 during the same quarter last year. Revenue for the quarter came in at $51.67 million versus the consensus estimate of $53.98 million.
Cooper Cos. (NYSE: COO) 3.8% HIGHER; reported Q1 EPS of $1.12, $0.08 better than the analyst estimate of $1.04. Revenue for the quarter came in at $326.1 million versus the consensus estimate of $317.15 million. Sees FY2012 EPS of $4.90-$5.15, versus prior guidance of $4.80-$5.00 and the consensus of $4.95.
Starbucks (Nasdaq: SBUX) 3.7% HIGHER; announces Verismo(R), new premium single cup solution.
Alon USA Energy, Inc. (NYSE: ALJ) 3.3% LOWER; reported Q4 EPS of ($0.78), which may not compare to the analyst estimate of ($0.11). Revenue for the quarter came in at $1.88 billion versus the consensus estimate of $1.92 billion.
Renren (NYSE: RENN) 2.9% HIGHER; reported Q4 EPS of $0.4, $0.02 better than the analyst estimate of $0.02. Revenue for the quarter came in at $32.8 million versus the consensus estimate of $32.28 million. Sees Q1 revenue of $28-$30 million, versus the consensus of $30.9 million. Sees FY2012 revenue of $177-$183 million, vs. the consensus of $175.14 million.
Smith & Wesson Holding Corp. (NASDAQ: SWHC) 2.7% HIGHER; reported Q3 EPS of $0.08, $0.04 better than the analyst estimate of $0.04. Revenue for the quarter came in at $98.1 million versus the consensus estimate of $95.24 million. Sees Q4 sales of $113-$118 million, which compares to the Street estimate of $114 million. Raises its FY12 sales guidance to $395-$400 million, which compares to the Street estimate of $393.1 million.
ARMOUR Residential REIT, Inc. (NYSE: ARR) 2.5% LOWER; is commencing an underwritten public offering of 26,000,000 shares of common stock. ARMOUR expects to grant the underwriters a 30-day option to purchase up to 3,900,000 additional shares of common stock.
Emergent Biosolutions (NYSE: EBS) 2.4% HIGHER; reported Q4 EPS of $0.78, $0.06 better than the analyst estimate of $0.72. Revenue for the quarter came in at $107.95 million versus the consensus estimate of $109.32 million. Emergent Biosolutions (reaffirms), seeing FY2012 revenue of $280-$300 million, versus the consensus of $304.5 million.
Fushi Copperweld, Inc. (NASDAQ: FSIN) 2.3% LOWER; reported Q4 EPS of $0.15, $0.07 worse than the analyst estimate of $0.22. Revenue for the quarter came in at $68.2 million versus the consensus estimate of $70.07 million. Sees FY2012 EPS of $0.76-$0.86, versus the consensus of $1.13.
Complete Genomics, Inc. (NASDAQ: GNOM) 2.1% LOWER; reported Q4 EPS of ($0.67), $0.02 worse than the analyst estimate of ($0.65). Revenue for the quarter came in at $2.5 million versus the consensus estimate of $3.15 million. Sees sequencing 1,100-1,300 genomes during Q1.
Molycorp (NYSE: MCP) 2% HIGHER;to buy Neo Material Technologies for about C$1.3 billion
Aeropostale, Inc. (NYSE: ARO) 1.9% LOWER; reported Q4 EPS of $0.44, $0.06 better than the analyst estimate of $0.38. Revenue for the quarter came in at $808.4 million versus the consensus estimate of $804.56 million. Comps down 9%. Aeropostale, Inc. sees Q1 2012 EPS of $0.08-$0.10, versus the consensus of $0.12.
Green Mountain (Nasdaq: GMCR) 16.5% LOWER; shares slammed as Starbucks announced Verismo, a new Premium Single Cup Solution for At-Home Espresso and Coffee Beverages.
Zogenix, Inc. (NASDAQ: ZGNX) 14% LOWER; reported Q4 EPS of ($0.36), $0.02 worse than the analyst estimate of ($0.34). Revenue for the quarter came in at $7.9 million versus the consensus estimate of $10.03 million. Sees FY2012 revenue of $45.5-$48.5 million, versus the consensus of $64.9 million.
WuXi PharmaTech (NYSE: WX) 5.2% HIGHER; reported Q4 EPS of $0.36, $0.10 better than the analyst estimate of $0.26. Revenue for the quarter came in at $108.5 million versus the consensus estimate of $106.87 million. Sees FY2012 revenue of $468-$488 million, versus the consensus of $464.6 million. Sees Q1 2012 revenue of $114-$117 million, versus the consensus of $108 million.
Heckmann (NYSE: HEK) 5% LOWER; reported Q4 loss of $2.48 million, compared to a gain of $279,000 during the same quarter last year. Revenue for the quarter came in at $51.67 million versus the consensus estimate of $53.98 million.
Cooper Cos. (NYSE: COO) 3.8% HIGHER; reported Q1 EPS of $1.12, $0.08 better than the analyst estimate of $1.04. Revenue for the quarter came in at $326.1 million versus the consensus estimate of $317.15 million. Sees FY2012 EPS of $4.90-$5.15, versus prior guidance of $4.80-$5.00 and the consensus of $4.95.
Starbucks (Nasdaq: SBUX) 3.7% HIGHER; announces Verismo(R), new premium single cup solution.
Alon USA Energy, Inc. (NYSE: ALJ) 3.3% LOWER; reported Q4 EPS of ($0.78), which may not compare to the analyst estimate of ($0.11). Revenue for the quarter came in at $1.88 billion versus the consensus estimate of $1.92 billion.
Renren (NYSE: RENN) 2.9% HIGHER; reported Q4 EPS of $0.4, $0.02 better than the analyst estimate of $0.02. Revenue for the quarter came in at $32.8 million versus the consensus estimate of $32.28 million. Sees Q1 revenue of $28-$30 million, versus the consensus of $30.9 million. Sees FY2012 revenue of $177-$183 million, vs. the consensus of $175.14 million.
Smith & Wesson Holding Corp. (NASDAQ: SWHC) 2.7% HIGHER; reported Q3 EPS of $0.08, $0.04 better than the analyst estimate of $0.04. Revenue for the quarter came in at $98.1 million versus the consensus estimate of $95.24 million. Sees Q4 sales of $113-$118 million, which compares to the Street estimate of $114 million. Raises its FY12 sales guidance to $395-$400 million, which compares to the Street estimate of $393.1 million.
ARMOUR Residential REIT, Inc. (NYSE: ARR) 2.5% LOWER; is commencing an underwritten public offering of 26,000,000 shares of common stock. ARMOUR expects to grant the underwriters a 30-day option to purchase up to 3,900,000 additional shares of common stock.
Emergent Biosolutions (NYSE: EBS) 2.4% HIGHER; reported Q4 EPS of $0.78, $0.06 better than the analyst estimate of $0.72. Revenue for the quarter came in at $107.95 million versus the consensus estimate of $109.32 million. Emergent Biosolutions (reaffirms), seeing FY2012 revenue of $280-$300 million, versus the consensus of $304.5 million.
Fushi Copperweld, Inc. (NASDAQ: FSIN) 2.3% LOWER; reported Q4 EPS of $0.15, $0.07 worse than the analyst estimate of $0.22. Revenue for the quarter came in at $68.2 million versus the consensus estimate of $70.07 million. Sees FY2012 EPS of $0.76-$0.86, versus the consensus of $1.13.
Complete Genomics, Inc. (NASDAQ: GNOM) 2.1% LOWER; reported Q4 EPS of ($0.67), $0.02 worse than the analyst estimate of ($0.65). Revenue for the quarter came in at $2.5 million versus the consensus estimate of $3.15 million. Sees sequencing 1,100-1,300 genomes during Q1.
Molycorp (NYSE: MCP) 2% HIGHER;to buy Neo Material Technologies for about C$1.3 billion
Aeropostale, Inc. (NYSE: ARO) 1.9% LOWER; reported Q4 EPS of $0.44, $0.06 better than the analyst estimate of $0.38. Revenue for the quarter came in at $808.4 million versus the consensus estimate of $804.56 million. Comps down 9%. Aeropostale, Inc. sees Q1 2012 EPS of $0.08-$0.10, versus the consensus of $0.12.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- After-Hours Movers: AMAT, DLO, GLOB, YSS, ETON
- Estée Lauder expected to post 1.8% Q4 sales growth as skincare rebounds
- Walmart expected to beat Q2 estimates as tariff refunds lift margins
Create E-mail Alert Related Categories
Special ReportsRelated Entities
After-Hours MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
